Algert Global’s Ventyx Biosciences VTYX Stock Holding History

Algert Global’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,050	Closed	-$208K	–	1351
2025 Q4	$208K	Sell	23,050 -20,270	-47%	-$151K	﹤0.01%	1052
2025 Q3	$135K	Sell	43,320 -28,240	-39%	-$74.8K	﹤0.01%	1072
2025 Q2	$153K	Buy	71,560 +45,070	+170%	+$72.8K	﹤0.01%	1117
2025 Q1	$30K	Hold	26,490	–	–	﹤0.01%	1159
2024 Q4	$58K	Hold	26,490	–	–	﹤0.01%	1141
2024 Q3	$58K	Buy	+26,490	New	+$60.9K	﹤0.01%	1141
2024 Q1	–	Sell	-96,970	Closed	-$240K	–	1291
2023 Q4	$240K	Buy	+96,970	New	+$921K	0.01%	988

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Algert Global's VTYX Position: Q1 2026 in Review

Algert Global sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 23,050 shares — an estimated $208K sold.

Algert Global first reported a position in VTYX in Q4 2023 and held it in 7 quarters. The position peaked at $240K in Q4 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Algert Global reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Algert Global sold 23,050 Ventyx Biosciences shares in Q1 2026, an estimated $208K.
Algert Global first reported a position in Ventyx Biosciences in Q4 2023 and held it in 7 quarters.
Algert Global's Ventyx Biosciences position peaked at $240K in Q4 2023.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.